✦ LIBER ✦

PCN27 COMPARATIVE BUDGET IMPACT OF FORMULARY INCLUSION OF ZOLEDRONIC ACID AND DENOSUMAB FOR PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES

✍ Scribed by M.J. Bell; J.D. Miller; M. Namjoshi; M.W. Russell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN26 BUDGET IMPACT MODEL OF DENOSUMAB F

✍ K. Northridge; A. Richhariya; M. Halperin; K. Chung; M.D. Danese 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCN132 MODELING THE LIFETIME EFFECTIVENE

✍ M.D. Danese; A. Bracco; D. Macarios; K. Chung; A. Barlev; M. Halperin; M. Lothgr 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PCN116 Cost-Effectiveness of Denosumab V

✍ Lothgren, M.; Bracco, A.; Lucius, B.; Northridge, K.; Halperin, M.; Macarios, D. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Cost-effectiveness of denosumab vs zoled

✍ Stopeck, Alison; Rader, Michael; Henry, David; Danese, Mark; Halperin, Marc; Con 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 264 KB

869 Prevention of symptomatic skeletal e

✍ Fizazi, K.; Coleman, R.; Klotz, L.; Pittman, K.; Milecki, P.; Costa, L.; Von Moo 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 113 KB

PCN71 A COMPARISON OF THE COST-EFFECTIVE

✍ M Botteman; J Carter; S Kaura 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB